Key facts
- It has raised $15.5M; the latest was Early Stage VC ($15.0M) in May 2024.
- Notable investors include NFX, Operator Partners, Ronald Cohen, Danielle Yanai, Deloitte Launchpad — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Opmed.ai
- ·The full record, as it builds
Funding rounds
No funding rounds for Opmed.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Opmed.ai
Developer of healthcare automation platform designed to reassign resources and staff in dynamic response to changing situations in the near and far future. The company's platform is based on artificial intelligence and network science and allows end-to-end process optimization, enabling healthcare organizations to increase various metrics, including revenue, capacity, and resource utilization, and mitigating risks and unexpected events in real-time.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2020
- Employees
- 43
- Website
- opmed.ai/
- Ownership
- Privately Held (backing)
Opmed.ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Opmed.ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Opmed.ai in its N-PORT filings yet. We sweep new filings monthly.